• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION ENVEO PRO DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION ENVEO PRO DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number ENVPRO-16
Device Problems Difficult or Delayed Positioning (1157); Fracture (1260); Material Separation (1562)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/04/2019
Event Type  malfunction  
Manufacturer Narrative
Analysis: upon receipt at medtronic's quality laboratory, the capsule and a portion of the middle member and outer shaft of the delivery catheter system (dcs) were received for analysis.The rest of the dcs was not returned.Delamination was observed over the nitinol reinforcing frame along the mid-section to the proximal end of the capsule.A break was observed in the capsule nitinol reinforcing frame near the proximal end of the capsule.Conclusion: the investigation is in progress.Following completion of the investigation, a supplemental report will be submitted.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, into a patient with aortic insufficiency, the valve was recaptured four times.The system was withdrawn from the patient and a new valve and delivery catheter system were used for implant.No adverse patient effects were reported.
 
Manufacturer Narrative
Conclusion: the lot number of the subject delivery catheter system (dcs) is not known, and therefore a device history record (dhr) review could not be performed on the dcs.However, manufacturing controls are in place to ensure that the device met specification requirements prior to release from the manufacturing facility.The reported event indicates that the valve was recaptured four times, however the reason for the recaptures was not reported.The evolut system instructions for use (ifu) instructs "deployment of the bioprosthesis can be attempted 3 times.If the bioprosthesis is recaptured a third time, it must be removed from the patient".Recapturing is a feature of the evolut system that allows for additional attempts at accurately positioning the valve.Various factors can affect valve positioning including patient anatomy or physician technique but the cause of the potential positioning difficulty could not be conclusively determined with the available evidence.Positioning difficulties do not typically indicate a device malfunction or a failure to meet manufacturing specifications.The capsule and a portion of the middle member and outer shaft was returned to medtronic for analysis.The remainder of dcs was not returned.The dcs may have been severed at the outer shaft after the event occurred, however based on the event description, it cannot be determined why or how the device was severed.Delamination was observed on the capsule, which typically occurs when the capsule is subjected to a bending force potentially after tracking through patient anatomy.Additionally, there was a break observed at the proximal end of the nitinol frame of the capsule.The investigation completed into capsule separation found that there is no evidence that the product fails to meet specification and these events are most likely not related to a fault condition of the device.The exact root cause of capsule separation is unknown however, patient anatomy (vessel tortuosity <(>&<)> calcification) and use conditions due to challenging anatomy (insertion angle, force required to advance, torqueing of the catheter) are known potential contributing factors to capsule damage.The four recaptures, outside ifu recommenda tion, may have also contributed to the capsule damage.However, as no capsule damage was reported in the event, the cause of the damage cannot be determined.It was reported that the system was removed and a new valve and dcs were used for implant.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVEO PRO DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
MDR Report Key9782340
MDR Text Key182004967
Report Number2025587-2020-00664
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 04/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberENVPRO-16
Device Catalogue NumberENVPRO-16
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/26/2019
Initial Date Manufacturer Received 02/03/2020
Initial Date FDA Received03/03/2020
Supplement Dates Manufacturer Received04/07/2020
Supplement Dates FDA Received04/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age80 YR
-
-